Biophotonics methods for functional monitoring of complications of diabetes mellitus |
|
Author: | Zharkikh, Elena1; Dremin, Viktor1,2; Zherebtsov, Evgeny1,3; |
Organizations: |
1Research & Development Center of Biomedical Photonics, Orel State University, Orel, Russia 2School of Engineering and Applied Science, Aston University, Birmingham, UK 3Optoelectronics and Measurement Techniques unit, University of Oulu, Oulu, Finland
4Interdisciplinary Laboratory of Biophotonics, National Research Tomsk State University, Tomsk, Russia
5Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University—MEPhI, Moscow, Russia 6School of Life and Health Sciences, Aston University, Birmingham, UK 7Department of Histology, Cytology and Embryology, Institute of Clinical Medicine N.V. Sklifosovsky, I.M. Sechenov First Moscow State Medical University, Moscow, Russia |
Format: | article |
Version: | published version |
Access: | open |
Online Access: | PDF Full Text (PDF, 8 MB) |
Persistent link: | http://urn.fi/urn:nbn:fi-fe2020120399207 |
Language: | English |
Published: |
John Wiley & Sons,
2020
|
Publish Date: | 2020-12-03 |
Description: |
AbstractThe prevalence of diabetes complications is a significant public health problem with a considerable economic cost. Thus, the timely diagnosis of complications and prevention of their development will contribute to increasing the length and quality of patient life, and reducing the economic costs of their treatment. This article aims to review the current state‐of‐the‐art biophotonics technologies used to identify the complications of diabetes mellitus and assess the quality of their treatment. Additionally, these technologies assess the structural and functional properties of biological tissues, and they include capillaroscopy, laser Doppler flowmetry and hyperspectral imaging, laser speckle contrast imaging, diffuse reflectance spectroscopy and imaging, fluorescence spectroscopy and imaging, optical coherence tomography, optoacoustic imaging and confocal microscopy. Recent advances in the field of optical noninvasive diagnosis suggest a wider introduction of biophotonics technologies into clinical practice and, in particular, in diabetes care units. see all
|
Series: |
Journal of biophotonics |
ISSN: | 1864-063X |
ISSN-E: | 1864-0648 |
ISSN-L: | 1864-063X |
Volume: | 13 |
Issue: | 10 |
Article number: | e202000203 |
DOI: | 10.1002/jbio.202000203 |
OADOI: | https://oadoi.org/10.1002/jbio.202000203 |
Type of Publication: |
A1 Journal article – refereed |
Field of Science: |
217 Medical engineering 3121 General medicine, internal medicine and other clinical medicine |
Subjects: | |
Funding: |
VD acknowledges personal support from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement No. 839888. EZ acknowledges personal support from the Academy of Finland (grant 318281). IM acknowledge partial support from MEPhI Academic Excellence Project (Contract No. 02.a03.21.0005) and the National Research Tomsk State University Academic D.I. Mendeleev Fund Program. Authors also acknowledge the support of the Academy of Finland (grants 326204, 325097). |
Academy of Finland Grant Number: |
318281 326204 325097 |
Detailed Information: |
318281 (Academy of Finland Funding decision) 326204 (Academy of Finland Funding decision) 325097 (Academy of Finland Funding decision) |
Copyright information: |
© 2020 The Authors. Journal of Biophotonics published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited |
https://creativecommons.org/licenses/by/4.0/ |